Who
Tibor Keler
Executive VP & Cso
Company insider
Files Form 4 as: Executive VP & Cso, Celldex Therapeutics.
In numbers
- Trades disclosed
- 28
- Buys
- 5
- Sells
- 1
- Bought
- $65K
- Sold
- $623K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Jan 2009
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —93,000 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —93,000 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —92,000 at $0.00 | filing |
| 7 Dec 2022filed 9 Dec 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —16,860 at $0.00 | filing |
| 7 Dec 2022filed 9 Dec 2022 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $47K16,860 at $2.78 | filing |
| 7 Dec 2022filed 9 Dec 2022 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $623K16,860 at $36.93 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —91,000 at $0.00 | filing |
| 17 Jun 2021filed 21 Jun 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —91,000 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —108,000 at $0.00 | filing |
| 9 Jun 2020filed 10 Jun 2020 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Bought | $15K5,000 at $2.99 | filing |
| 19 Jun 2019filed 20 Jun 2019 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 15 Jun 2018filed 18 Jun 2018 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Bought | $9,73516,500 at $0.59 | filing |
| 13 Jun 2018filed 15 Jun 2018 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —390,000 at $0.00 | filing |
| 15 Jun 2017filed 16 Jun 2017 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —162,000 at $0.00 | filing |
| 2 Sep 2016filed 6 Sep 2016 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Bought | $9,9603,000 at $3.32 | filing |
| 8 Jun 2016filed 9 Jun 2016 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —162,000 at $0.00 | filing |
| 10 Jun 2015filed 11 Jun 2015 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —116,500 at $0.00 | filing |
| 4 Jun 2014filed 5 Jun 2014 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —116,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.